Dr. Mohamed Shalaby, M.D.
What this data tells you about Dr. Shalaby
Dr. Mohamed Shalaby is a cardiovascular disease in Webster, TX, with 20 years in practice. Based on federal Medicare data, Dr. Shalaby performed 5,440 Medicare services across 3,538 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shalaby received a total of $8,970 from 40 pharmaceutical and/or device companies across 343 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shalaby is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 816 | $44 | $150 |
| Office visit, established patient (30-39 min) | 747 | $93 | $400 |
| Electrocardiogram (EKG), 12-lead | 524 | $11 | $45 |
| Echocardiogram, transthoracic | 498 | $125 | $1,200 |
| Ultrasound of both sides of head and neck blood flow | 419 | $148 | $615 |
| Office visit, established patient, complex (40-54 min) | 395 | $133 | $564 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 261 | $294 | $563 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 225 | $56 | $226 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 184 | $1,914 | $7,500 |
| Hospital follow-up visit, high complexity | 110 | $96 | $304 |
| Heart muscle strain imaging | 106 | $29 | $121 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 96 | $676 | $2,814 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 94 | $20 | $80 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 94 | $92 | $380 |
| Blood draw (venipuncture) | 60 | $8 | $60 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 54 | $136 | $604 |
| Ultrasound of leg arteries or artery grafts | 47 | $179 | $778 |
| Initial hospital admission, high complexity | 42 | $140 | $583 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 39 | $1,054 | $4,343 |
| Ultrasound study of arm and leg arteries | 39 | $57 | $262 |
| New patient office visit, complex (60-74 min) | 37 | $143 | $690 |
| Lipid panel (cholesterol and triglycerides) | 32 | $13 | $50 |
| Albumin (protein) level | 32 | $5 | $19 |
| Amylase (enzyme) level | 32 | $6 | $24 |
| Bilirubin level, total | 32 | $5 | $20 |
| Calcium level, total | 32 | $5 | $20 |
| Blood creatinine level | 32 | $5 | $20 |
| Blood glucose (sugar) level | 32 | $4 | $15 |
| Glutamyltransferase (liver enzyme) level | 32 | $7 | $27 |
| Phosphatase (enzyme) level, alkaline | 32 | $5 | $20 |
| Total protein level, blood | 32 | $4 | $15 |
| Liver enzyme (sgot), level | 32 | $5 | $20 |
| Liver enzyme (sgpt), level | 32 | $5 | $21 |
| Urea nitrogen level to assess kidney function, quantitative | 32 | $4 | $15 |
| Uric acid level test | 32 | $4 | $18 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 32 | $70 | $398 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 30 | $882 | $3,553 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $345 | $1,433 |
| Programming of dual lead pacemaker system | 20 | $60 | $260 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shalaby is a cardiac imaging specialist, with above-average Medicare volume (top 14% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shalaby experienced with regadenoson injection (lexiscan) for heart stress test?
Does Dr. Shalaby receive payments from pharmaceutical companies?
How do Dr. Shalaby's costs compare to other cardiovascular diseases in Webster?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology